TipRanks

Paul Silva Insider Profile

4 Followers
Paul Silva, Director at Rapport Therapeutics, Inc., holds 3.68K shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 10.05K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds ― shares in Nurix Therapeutics (Ticker: NRIX). Most recently, Paul Silva Bought ― shares of Rapport Therapeutics, Inc. on Oct 22, 2026 for an estimated value of $99.62K.
tipranks
Paul Silva

Paul Silva
Rapport Therapeutics, Inc. (RAPP)
Director

Not Ranked
Paul Silva has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
98.24%
1.76%
0.00%
A breakdown of Paul Silva's holdings

Insider Roles

Vertex Pharmaceuticals
(VRTX)
SVP & CAO
Rapport Therapeutics, Inc.
(RAPP)
Director
Nurix Therapeutics
(NRIX)
Director
Roles that Paul Silva holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Paul Silva

Paul Silva's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Rapport Therapeutics, Inc.
Oct 22, 2026
Director
Informative Buy
99.62K
$93.21K
Vertex Pharmaceuticals
Mar 02, 2021
SVP & CAO
Uninformative Sell
588.26K
$5.20M
Nurix Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Paul Silva's performance on stock

Paul Silva insider profile FAQ

What is the percentage of profitable transactions made by Paul Silva?
The percentage of profitable transactions made by Paul Silva is ―.
    What is the average return per transaction made by Paul Silva?
    The average return per transaction made by Paul Silva is ―.
      What stocks does Paul Silva hold?
      Paul Silva holds: RAPP, VRTX, NRIX stocks.
        What was Paul Silva’s latest transaction?
        Paul Silva latest transaction was an Informative Buy of $99.62K.
          What was Paul Silva's most profitable transaction?
          Paul Silva’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Paul Silva's role in Rapport Therapeutics, Inc.?
            Paul Silva's role in Rapport Therapeutics, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.